You are here
GRS USRS
4
Research, Clinical Trials, Vaccines, Epidemic, Pandemic
> Begin forwarded message:
>
> From: "Fedeczko, Joyce <jfedeczko@ifdc.org>" <jfedeczko@ifdc.org>
> Subject: You may have seen this already ...
> Date: April 26, 2017 at 12:04:38 PM EDT
> To: "michael.d.mcdonald@mac.com" <michael.d.mcdonald@mac.com>
>
> Hey, Mike:
> From earlier this month: http://tinyurl.com/mtxbvt5 <http://tinyurl.com/mtxbvt5>
> New Report Outlines How to Improve the Speed, Effectiveness of Clinical Trials During an Epidemic <http://tinyurl.com/mtxbvt5>
> tinyurl.com <http://tinyurl.com/>
> Mobilization of a rapid and robust clinical research program that explores whether investigational therapeutics and vaccines are safe and effective to combat the next infectious disease epidemic will depend on strengthening capacity in low-income countries for response and research, engaging people living in affected communities, and conducting safety trials before an epidemic hits, says a new report from the National Academies of Sciences, Engineering, and Medicine.
>
> Joyce L. Fedeczko, MALS
> Managing Librarian and Archivist
> Office of Communications
> P.O. Box 2040 [Reservation Road, Complex F, 35661]
> Muscle Shoals, Alabama 35662 USA
> (: +1 256-381-6600 Ext 361 | 7: +1 256-381-7408 | *: jfedeczko@ifdc.org <mailto:jfedeczko@ifdc.org>
> www.ifdc.org <http://www.ifdc.org/>
> "An uncertain world demands more investment in research, not less."
> -- Bill & Melinda Gates Foundation
> NOTICE: This email, and any attachments hereto, may contain information that is confidential and/or privileged. It is intended solely for the holder of the email address to which it has been directed. If you are not the intended recipient, you are hereby notified that any dissemination, distribution, printing or copying of this email or its attachments is strictly prohibited. If you have received this email in error, please notify us by replying to this email, and please delete this email and any attachments without copying or forwarding.
Recent Comments